Habit Reversal Training a Valid Drug Alternative for Tics
Publish date: February 1, 2011
A PSYCHOPHARMACOLOGY UPDATE
Dr. McCracken said he is an adviser to BioMarin Pharmaceutical Inc., and receives research funding from Bristol-Myers Squibb and Seaside Pharmaceutical.
